): The goal of the Clinical Scientist T r aining Program in Cancer Gene Medicine is to train physicians in translational research relevant to clinical gene therapy. The training infrastructure is provided by an established and successful interdisciplinary UCLA Gene Medicine Program that was initiated with institutional support. This Program has now reached a stage of scientific maturity and depth that justifies the formation of a formal, long-term, multidisciplinary cancer-directed Training Program. The Program will help fulfill a national need for translationally-based clinical investigators in this field. The proposal requests two years of training support for six M.D. trainees to assist in achieving the Training Program's goals. T h e T raining Program is heavily weighted toward training clinical translational research investigators, but recognizes the necessity for a strong scientific base in virology, molecular biology, and cell physiology. To this end, it involves a subset of 24 members of the UCLA Gene Medicine Program Faculty whose research and educational focus best match the goals of the Training Program. The Faculty have their principal appointments in seven clinical and four basic science departments. Several talented junior faculty are included who will have the opportunity to co-mentor trainees along with experienced senior faculty. Trainee programs will be monitored throughout and final success of the Training Program will be judged by trainee placement in academia and their ability to compete successfully for individual research grants. The Training Program will be administered by four committees--Advisory, Recruitment, Education, and Training - all of which report to the Program Director. The Training Program will have several major educational elements: (1) multidisciplinary research training in Cancer Gene Medicine under the direction of an established investigator, (2) formal course work to establish sound background knowledge and (3) required participation in advanced research conferences, including the Annual UCLA Gene Therapy Symposium, laboratory workshops, affinity research group meetings, and courses in grant writing, biostatistics, and ethics course. It will involve all clinical oncology departments at UCLA. The Program, with its highly interactive multidisciplinary but thematically focused faculty, provides an outstanding training environment for the next generation of Gene Medicine investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
5K12CA076905-03
Application #
2896321
Study Section
Special Emphasis Panel (ZCA1-GRB-J (01))
Program Officer
Lei, Ming
Project Start
1997-09-30
Project End
2002-06-30
Budget Start
1999-08-19
Budget End
2000-06-30
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Surgery
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Lasky 3rd, Joseph L; Panosyan, Eduard H; Plant, Ashley et al. (2013) Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas. Anticancer Res 33:2047-56
Sawey, Eric T; Chanrion, Maia; Cai, Chunlin et al. (2011) Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. Cancer Cell 19:347-58
Finn, Richard S; Bentley, Greg; Britten, Carolyn D et al. (2009) Targeting vascular endothelial growth factor with the monoclonal antibody bevacizumab inhibits human hepatocellular carcinoma cells growing in an orthotopic mouse model. Liver Int 29:284-90
Lukacs, R U; Lawson, D A; Xin, L et al. (2008) Epithelial stem cells of the prostate and their role in cancer progression. Cold Spring Harb Symp Quant Biol 73:491-502
Lee, Jay M; Yanagawa, Jane; Peebles, Katherine A et al. (2008) Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment. Crit Rev Oncol Hematol 66:208-17
Peebles, Katherine A; Lee, Jay M; Mao, Jenny T et al. (2007) Inflammation and lung carcinogenesis: applying findings in prevention and treatment. Expert Rev Anticancer Ther 7:1405-21
Memarzadeh, Sanaz; Xin, Li; Mulholland, David J et al. (2007) Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor. Cancer Cell 12:572-85
Lasky, Joseph L; Liau, Linda M (2006) Targeting stem cells in brain tumors. Technol Cancer Res Treat 5:251-60
Schumacher, Lana Y; Vo, Dan D; Garban, Hermes J et al. (2006) Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade). J Immunol 176:4757-65
Ribas, Antoni; Vo, Dan D; Weeks, David L et al. (2006) Broad antitumor protection by dendritic cells administered to CD8alpha knock out mice. Cancer Immunol Immunother 55:663-71

Showing the most recent 10 out of 29 publications